HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of the Copper(II) Complex Cu[15]pyN5 in Intracellular ROS and Breast Cancer Cell Motility and Invasion.

Abstract
Multiple mechanisms related to metastases undergo redox regulation. Cu[15]pyN5 is a redox-active copper(II) complex previously studied as a chemotherapy sensitizer in mammary cells. The effects of a cotreatment with Cu[15]pyN5 and doxorubicin (dox) were evaluated in two human breast cancer cell lines: MCF7 (low aggressiveness) and MDA-MB-231 (highly aggressive). Cu[15]pyN5 decreased MCF7-directed cell migration. In addition, a cotreatment with dox and Cu[15]pyN5 reduced the proteolytic invasion of MDA-MB-231 cells. Cell detachment was not affected by exposure to these agents. Cu[15]pyN5 and dox significantly increased intracellular ROS in both cell lines. This increase could be at least partially due to H2 O2 accumulation. The combination of Cu[15]pyN5 with dox may be beneficial in breast cancer treatment as it could help reduce cancer cell migration and invasion. Moreover, the ligand [15]pyN5 has a high affinity for copper(II) and displays potential anti-angiogenic properties. Overall, we present a potential drug that might arrest the progression of breast cancer by different and complementary mechanisms.
AuthorsAna S Fernandes, Ana Flórido, Nuno Saraiva, Sara Cerqueira, Sérgio Ramalhete, Madalena Cipriano, Maria Fátima Cabral, Joana P Miranda, Matilde Castro, Judite Costa, Nuno G Oliveira
JournalChemical biology & drug design (Chem Biol Drug Des) Vol. 86 Issue 4 Pg. 578-88 (Oct 2015) ISSN: 1747-0285 [Electronic] England
PMID25600158 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 John Wiley & Sons A/S.
Chemical References
  • Antineoplastic Agents
  • Reactive Oxygen Species
  • Copper
  • Doxorubicin
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Movement (drug effects)
  • Copper (chemistry, pharmacology)
  • Doxorubicin (chemistry, pharmacology)
  • Female
  • Humans
  • MCF-7 Cells
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: